Conference Program
10:00am EST
Conference Opening & Welcome
Joshua Richter, M.D., Conference Chair
10:06am EST
Session 1
10:06 - 10:24
Optimizing Management of the triple-class refractory Myeloma patient
Andrew Yee
Massachusetts General Hospital Cancer Center, Boston, MA
10:24 - 10:45
Optimizing Management of the high-risk Myeloma patient
Artur Jurczyszyn
Jagiellonian University Medical College, Poland
10:45 - 11:10
Optimizing Management of the transplant eligible Myeloma patient
Neha Korde
Memorial Sloan Kettering Cancer Center, NY
11:10 - 11:26
Optimizing Management of the Geriatric Myeloma patient
Ashley Rosko
The Ohio State University, OH
11:26am EST
Break & Visit the Exhibition Area
11:33am EST
Session 2
11:33 - 11:54
Today and Tomorrow: BCMA Bi-specific Therapy in Myeloma
Alexander Lesokhin
Memorial Sloan Kettering Cancer Center, NY
11:54 - 12:13
Today and Tomorrow: non-BCMA bispecifics Myeloma
Suzanne Trudel
University Heath Network/Princess Margaret Hospital, Canada
12:13 - 12:27
Today and Tomorrow: BCMA CAR-T in Myeloma
Sandy Wong
University of California San Francisco, CA
12:27 - 12:50
Today and Tomorrow: non-BCMA CAR-T in Myeloma
Edward Stadtmauer
University of Pennsylvania, PA
12:50pm EST
LIVE Panel Discussion/Q&A
1:30pm EST
Break & Visit the Exhibition Area
1:42pm EST
Message from Sanofi
1:45pm EST
LIVE Satellite Symposium Sponsored by SANOFI
1:45 - 2:25
Sarclisa + KD: An Anti-CD38 Combination for the Treatment of Multiple Myeloma as Early as First Relapse: Updated Results from the Final PFS Analysis from the IKEMA Trial
Cristina Gasparetto
MD-Director, Multiple Myeloma Department at Duke Cancer Institute
2:25pm EST
Session 3
2:25 - 2:44
Is it ready for Prime time?: Treating Smoldering Myeloma
Irene Ghobrial
Dana-Farber Cancer Institute, Boston, MA
2:44 - 3:04
Is it Time to Use Genetic Information to Direct Treatment in the Clinic?
Gareth Morgan
NYU Langone Hospital, NY
3:04 - 3:28
Is it ready for Prime time?: Modifying treatment based on MRD
C. Ola Landgren
Sylvester Comprehensive Cancer Center, University of Miami, FL
3:28 - 3:52
Is it ready for Prime time?: Abandoning the stem cell transplant paradigm
Noa Biran
John Theurer Cancer Center, Hackensack, NJ
3:52pm EST
Break & Visit the Exhibition Area
3:58pm EST
Session 4
3:58 - 4:15
How I approach AL Amyloidosis in 2022
Suzanne Lentzsch
Columbia University, NY
4:15 - 4:40
How I approach maintenance therapy for Myeloma in 2022
Ajay Nooka
Emory University School of Medicine, Atlanta, GA
4:40 - 5:00
How I approach monoclonal gammopathies of other significance in 2022
Morie Gertz
Mayo Clinic, MN
5:00pm EST
LIVE Panel Discussion/Q&A
5:45pm EST
End of the Conference